Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen

Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen

Abstract PEG‐asparaginase is used as a treatment for Philadelphia‐negative acute lymphoblastic leukemia. In pediatric studies, triglycerides (TGs) were affected more by PEG‐asparaginase than by native L‐asparaginase (10.0% vs. 5.5%). We conducted a retrospective study to determine the safety of re‐c...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Ibrahim Al Nabhani, Claire Andrews, Jad Sibai, Eshetu Atenafu, Taylor Young, Steven M. Chan, Vikas Gupta, Dawn Maze, Aaron D. Schimmer, Andre C. Schuh, Karen Yee, Hassan Sibai
Formaat: Artikel
Taal:English
Gepubliceerd in: Wiley 2023-02-01
Reeks:eJHaem
Onderwerpen:
acute lymphoblastic leukemia
acute pancreatitis
hypertriglyceridemia
PEG‐asparaginase
toxicity
Online toegang:https://doi.org/10.1002/jha2.607

Internet

https://doi.org/10.1002/jha2.607

Gelijkaardige items